The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Celgene; Roche Pharma AG
Research Funding - Amgen (Inst); Novartis (Inst); Roche Pharma AG (Inst)
A randomized phase III trial comparing two dose-dense, dose-intensified approaches (EPC and PM(Cb)) for neoadjuvant treatment of patients with high-risk early breast cancer (GeparOcto).
 
Andreas Schneeweiss
No Relationships to Disclose
 
Volker Moebus
No Relationships to Disclose
 
Jens Uwe Blohmer
No Relationships to Disclose
 
Serban Dan Costa
No Relationships to Disclose
 
Carsten Denkert
No Relationships to Disclose
 
Holger Eidtmann
No Relationships to Disclose
 
Claus Hanusch
Honoraria - Amgen; Novartis; Pfizer
Consulting or Advisory Role - Amgen; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca
 
Joern Hilfrich
No Relationships to Disclose
 
Jens Bodo Huober
Consulting or Advisory Role - Novartis; Roche Pharma AG
Speakers' Bureau - Novartis; Roche Pharma AG
 
Christian Jackisch
Honoraria - Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
 
Stefan Paepke
No Relationships to Disclose
 
Sherko Kümmel
Honoraria - Celgene; Novartis; Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Travel, Accommodations, Expenses - Celgene; Roche Pharma AG
 
Hans Tesch
Honoraria - Roche Pharma AG; Vifor Pharma
Consulting or Advisory Role - Roche Pharma AG; Vifor Pharma
Travel, Accommodations, Expenses - Novartis; Roche Pharma AG
 
Michael Untch
No Relationships to Disclose
 
Sibylle Loibl
No Relationships to Disclose
 
Gunter Von Minckwitz
Employment - GBG Forschungs
Leadership - GBG Forschungs
Stock and Other Ownership Interests - GBG Forschungs
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Teva (Inst)